文献速递认知障碍与谵妄多重用药老年综合评估

家庭财富与痴呆患者潜在不适当用药:共病与照护者的作用

Household Wealth and Potentially Inappropriate Medications in Persons With Dementia: Role of Comorbidities and Caregivers.
PubMed 文献 · J Am Geriatr Soc · 2025-06-12

该研究纳入健康与退休研究中1475名≥66岁社区居住痴呆患者,76%接受至少一种潜在不适当用药(PIM)。调整人口学后,低于中位财富者PIM风险升高(OR=1.44),但进一步调整共病数后不再显著;共病≤2种时付费照护者与PIM风险升高相关。

要点

  • 痴呆患者中76%接受至少一种PIM,需重视用药审查。
  • 低财富与PIM的关联在调整共病数后不再显著。
  • 共病≤2种时,有付费照护者者PIM风险更高。

核心结论

  • 痴呆患者中低财富与PIM风险升高的关联在调整共病数后不再有统计学意义。
  • 照护者类型与PIM的关系因共病负担不同而复杂。

研究设计与样本

  • 基于健康与退休研究(2008-2018)的队列分析,纳入1475名≥66岁社区居住痴呆患者。
  • 采用带全国调查权重的logistic回归,比较家庭财富高于与低于样本中位数者接受≥1种PIM的比值比。
  • PIM包括镇静催眠药、强抗胆碱能药及2019 Beers和STOPP第2版标准中的药物。

主要发现

  • 队列中位年龄84岁,67%女性,15%黑人,中位家庭财富86,000美元(IQR 2000-315,000),49%仅有无偿照护者,23%有付费照护者。
  • 整体76%接受≥1种PIM。
  • 调整人口学后,低于中位财富者接受≥1种PIM的OR=1.44(95%CI 1.07-1.93)。
  • 进一步调整共病数后,OR=1.26(95%CI 0.93-1.70),无统计学意义。
  • 按共病数分层并调整人口学和财富后,共病≤2种者中付费照护者与PIM风险升高相关(OR=2.60,95%CI 1.44-4.69),共病≥3种者无关(OR=0.90,95%CI 0.50-1.62),交互p=0.02。

关键数值与推荐

  • PIM定义采用2019 Beers标准和STOPP第2版,包括镇静催眠药、强抗胆碱能药等。
  • 主要结局为接受≥1种PIM的处方。
  • 财富分组以样本中位数为界(高于 vs 低于)。
  • 共病数范围为0-7种。

临床怎么用

  • 对痴呆患者应常规审查PIM,尤其关注镇静催眠药和强抗胆碱能药。
  • 评估PIM风险时需考虑共病负担,低财富本身在调整共病后不是独立风险因素。
  • 共病较少的痴呆患者若有付费照护者,应加强PIM审查。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The association between lower socioeconomic status and increased potentially inappropriate medications (PIMs) among older adults, as seen in some studies, is infrequently studied in persons with dementia (PWD). This association may additionally be impacted by multimorbidity and caregiver support in PWD. Thus, we examined the association between wealth and PIMs in PWD and the effects of comorbidities and caregivers. METHODS: We included community-dwelling adults aged ≥ 66 with dementia in the Health and Retirement Study (2008-2018). PIMs included sedative-hypnotics, strongly anticholinergics, and medications from 2019 Beers and STOPP-Version 2 criteria. The primary outcome was a prescription for ≥ 1 PIM. We used logistic regression with national survey weights to examine the association between household wealth (above vs. below sample median) and ≥ 1 PIM through 4 models: (1) unadjusted, (2) adjusted for demographics (age, sex, race/ethnicity), 3) Model 2 + comorbidity count (range 0-7), (4) Model 3 + caregiver type (no caregiver, paid caregiver, unpaid caregiver only). RESULTS: The cohort consisted of 1475 PWD (median age 84, 67% female, 15% Black, median household wealth $86,000 (IQR 2000-315,000), 49% with unpaid caregiver only, 23% with paid caregiver). Overall, 76% received ≥ 1 PIM. Adjusting for demographics, PWD with below median wealth showed increased odds of receiving ≥ 1 PIM (OR = 1.44, 95% CI = 1.07-1.93). This association was not statistically significant after adjusting for comorbidity count (OR = 1.26, 95% CI = 0.93-1.70). In a stratified analysis by comorbidity count adjusting for demographics and wealth, paid caregiver presence was associated with increased odds of PIMs among individuals with ≤ 2 chronic conditions (OR = 2.60, 95% CI = 1.44-4.69) but not with ≥ 3 chronic conditions (OR = 0.90, 95% CI = 0.50-1.62) (p = 0.02 for interaction). CONCLUSIONS: Among PWD, the association between lower wealth and increased odds of PIMs was no longer statistically significant after adjusting for comorbidity count. Caregiving status had a complex relationship with PIMs based on comorbidity burden.

来源:J Am Geriatr Soc,查看原文。版权归原作者所有。

引用

  1. Deardorff WJ, Jing B, Growdon ME, et al. Household Wealth and Potentially Inappropriate Medications in Persons With Dementia: Role of Comorbidities and Caregivers. J Am Geriatr Soc. 2025. PMID: 40503752. doi:10.1111/jgs.19585

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。